查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1782619

全球家禽疫苗市场研究报告 - 产业分析、规模、份额、成长、趋势及预测（2025 年至 2033 年）

Global Poultry Vaccines Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033
出版日期: | 出版商: Value Market Research | 英文 171 Pages | 商品交期: 最快1-2个工作天内

价格

全球家禽疫苗市场规模预计将从 2024 年的 25.6 亿美元成长到 2033 年的 50.6 亿美元，在 2026 年至 2033 年的预测期内，年复合成长率(CAGR) 将达到 7.85%。

随着全球对健康无病家禽生产的需求持续成长，家禽疫苗市场正经历显着成长。疫苗接种是家禽健康管理的重要组成部分，有助于预防禽流感、新城疫和传染性支气管炎等疾病的爆发。随着食品安全意识的不断提高以及对永续家禽养殖实践的需求不断增长，对有效疫苗的需求预计将持续增长。随着市场的发展，重视研发、产品功效和合规性对于吸引寻求可靠疫苗解决方案的家禽生产商至关重要。

此外，疫苗技术的进步也提升了家禽疫苗的效力。重组疫苗、减毒活疫苗和灭活疫苗等创新技术使製造商能够开发出保护力更强、副作用更少的产品。水基疫苗和气雾剂疫苗等给药系统的整合也日益受到关注，从而提高了给药效率，并提高了家禽族群的免疫力。随着家禽疫苗市场的持续成长，对创新和消费者参与的关注将在其未来发展中发挥至关重要的作用。

此外，日益增长的生物安全措施和动物福利趋势正在影响家禽疫苗市场。随着生产者寻求将疾病风险降至最低并增强禽群健康，对符合这些目标的疫苗的需求也日益增长。这种转变促使製造商投资于行销和分销策略，以强调疫苗接种在促进家禽健康和生产力方面的优势。因此，家禽疫苗市场的未来将以对品质、创新和持续改进疫苗接种解决方案的承诺为特征，以满足家禽行业不断变化的需求。

我们的报告经过精心设计，旨在为客户提供关于各个行业和市场的全面且切实可行的洞察。每份报告都包含几个关键部分，以确保客户全面了解市场格局：

市场概览：市场的详细介绍，包括定义、分类和行业现状概述。

市场动态：深入分析影响市场成长的关键驱动因素、限制因素、机会与挑战。本部分探讨技术进步、监管变化和新兴趋势等因素。

細項分析：根据产品类型、应用、最终用户和地理位置等标准，将市场细分为不同的细分市场。此分析重点在于突出每个细分市场的表现和潜力。

竞争格局：对主要市场参与者的全面评估，包括其市场份额、产品组合、策略倡议和财务表现。本部分深入分析了竞争态势以及领先公司采用的关键策略。

市场预测：根据历史资料和当前市场状况，对特定时期的市场规模和成长趋势进行预测。这包括定量分析和图形表示，以说明未来的市场发展轨迹。

区域分析：评估不同地理区域的市场表现，确定关键市场和区域趋势。这有助于了解区域市场动态和机会。

新兴趋势与机会：识别当前及新兴市场趋势、技术创新以及潜在投资领域。本部分将深入探讨未来市场发展与成长前景。

目录

第一章：前言

  • 报告描述
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 产品
  • 研究范围
  • 研究方法
    • 市场研究流程
    • 市场研究方法

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第三章：家禽疫苗产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业趋势
  • 波特五力分析
  • 市场吸引力分析
    • 市场吸引力分析：按应用
    • 按产品进行市场吸引力分析
    • 依疾病类型分析市场吸引力
    • 市场吸引力分析：按地区

第四章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料製造商清单
    • 主要原物料价格走势
  • 潜在买家名单

第五章：行销通路

  • 直效行销
  • 间接行销
  • 行销通路发展趋势

第六章：全球家禽疫苗市场分析：依应用

  • 概述：按应用
  • 历史和预测数据
  • 分析：按应用
  • 肉鸡
  • 层
  • 饲养员

第七章：全球家禽疫苗市场分析：依产品

  • 产品概览
  • 历史和预测数据
  • 按产品分析
  • 减毒活疫苗
  • 灭活疫苗
  • 亚单位疫苗
  • DNA疫苗
  • 重组疫苗

第八章：全球家禽疫苗市场销售分析：依疾病类型

  • 疾病类型概览
  • 历史和预测数据
  • 依疾病类型分析
  • 传染性支气管炎
  • 传染性法氏囊病
  • 传染性喉气管炎
  • 鸡蛋掉落症
  • 腺病毒
  • 鸭子病毒性肠炎
  • 包涵体肝炎
  • 球虫病
  • 禽流感
  • 马立克氏症
  • 新城疫
  • 沙门氏菌
  • 禽脑脊髓炎
  • 禽霍乱

第九章：全球家禽疫苗市场销售分析：按地区

  • 区域展望销售分析
  • 简介 销售分析
  • 北美销售分析
    • 概述、历史和预测销售分析
    • 北美各细分市场销售分析
    • 北美各国销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概述、历史和预测销售分析
    • 欧洲各细分市场销售分析
    • 欧洲各国销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概述、历史和预测销售分析
    • 亚太地区分部销售分析
    • 亚太地区国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概述、历史和预测销售分析
    • 拉丁美洲各细分市场销售分析
    • 拉丁美洲各国销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东非洲销售分析
    • 概述、历史和预测销售分析
    • 中东非洲各细分市场销售分析
    • 中东非洲国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东和非洲其他地区销售分析

第十章：家禽疫苗公司的竞争格局

  • 家禽疫苗市场竞争
  • 合作/协作/协议
  • 合併与收购
  • 新产品发布
  • 其他发展

第 11 章：公司简介

  • 十大公司股票分析
  • 市场集中度
  • Boehringer Ingelheim International GmbH
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Ceva
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Zoetis
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Elanco
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Intervet Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Merck Co. Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Hester Biosciences Limited
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Vaxxinova International BV
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Venkys India
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Calier
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • KM Biologics
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Phibro Animal Health Corporation
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

注意 - 在公司简介中，财务细节和近期发展取决于可用性，如果是私人公司，则可能不予涵盖

Product Code: VMR112110059

Global Poultry Vaccines Market size is anticipated to grow from USD 2.56 Billion in 2024 to USD 5.06 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 7.85% during the forecast period of 2026 to 2033.

The poultry vaccines market is experiencing significant growth as the demand for healthy and disease-free poultry production continues to rise globally. Vaccination is a crucial component of poultry health management, helping to prevent outbreaks of diseases such as avian influenza, Newcastle disease, and infectious bronchitis. With the increasing awareness of food safety and the need for sustainable poultry farming practices, the demand for effective vaccines is expected to grow. As the market evolves, the emphasis on research and development, product efficacy, and regulatory compliance will be crucial in attracting poultry producers seeking reliable vaccination solutions.

Moreover, advancements in vaccine technology are enhancing the capabilities of poultry vaccines. Innovations such as recombinant vaccines, live attenuated vaccines, and inactivated vaccines are enabling manufacturers to develop products that offer improved protection and reduced side effects. The integration of delivery systems, such as water-based and aerosol vaccines, is also gaining traction, allowing for more efficient administration and better uptake among poultry populations. As the poultry vaccines market continues to grow, the focus on innovation and consumer engagement will play a vital role in shaping its future trajectory.

In addition, the growing trend of biosecurity measures and animal welfare is influencing the poultry vaccines market. As producers seek to minimize disease risks and enhance the health of their flocks, there is a rising demand for vaccines that align with these goals. This shift is prompting manufacturers to invest in marketing and distribution strategies that highlight the benefits of vaccination in promoting poultry health and productivity. The future of the poultry vaccines market is thus characterized by a commitment to quality, innovation, and the continuous improvement of vaccination solutions to meet the evolving needs of the poultry industry.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Product Type

  • Modified or Attenuated (Live)
  • Inactivated (Killed)
  • Recombinants

By Dosage Form

  • Liquid Vaccine
  • Freeze Dried Vaccine
  • Duct

By Disease Type

  • Newcastle Disease
  • Marek's Disease
  • Infectious Bronchitis
  • Infectious Bursal Disease
  • Others

By Application

  • Breeder
  • Broiler
  • Layer

By End User

  • Hospitals
  • Poultry Vaccination Centres
  • Poultry Firms
  • COMPANIES PROFILED
  • Zoetis
  • Boehringer Ingelheim
  • Merck Animal Health
  • Elanco Animal Health
  • Dechra Pharmaceuticals
  • Phibro Animal Health
  • Hester Biosciences
  • Novartis Animal Health
  • Ceva Sante Animale
  • Venky's India Ltd.
  • The above list can be customized.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . POULTRY VACCINES INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Application
    • 3.7.2 Market Attractiveness Analysis By Product
    • 3.7.3 Market Attractiveness Analysis By Disease Type
    • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers

5. MARKETING CHANNEL

  • 5.1. Direct Marketing
  • 5.2. Indirect Marketing
  • 5.3. Marketing Channel Development Trend

6 . GLOBAL POULTRY VACCINES MARKET ANALYSIS BY APPLICATION

  • 6.1 Overview by Application
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Application
  • 6.4 Broiler Historic and Forecast Sales by Regions
  • 6.5 Layer Historic and Forecast Sales by Regions
  • 6.6 Breeder Historic and Forecast Sales by Regions

7 . GLOBAL POULTRY VACCINES MARKET ANALYSIS BY PRODUCT

  • 7.1 Overview by Product
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Product
  • 7.4 Attenuated Live Vaccines Historic and Forecast Sales by Regions
  • 7.5 Inactivated Vaccines Historic and Forecast Sales by Regions
  • 7.6 Subunit Vaccines Historic and Forecast Sales by Regions
  • 7.7 DNA Vaccines Historic and Forecast Sales by Regions
  • 7.8 Recombinant Vaccines Historic and Forecast Sales by Regions

8 . GLOBAL POULTRY VACCINES MARKET SALES ANALYSIS BY DISEASE TYPE

  • 8.1 Overview by Disease Type
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Disease Type
  • 8.4 Infectious Bronchitis Historic and Forecast Sales by Regions
  • 8.5 Infectious Bursal Diseases Historic and Forecast Sales by Regions
  • 8.6 Infectious Laryngotracheitis Historic and Forecast Sales by Regions
  • 8.7 Egg Drop Syndrome Historic and Forecast Sales by Regions
  • 8.8 Adenovirus Historic and Forecast Sales by Regions
  • 8.9 Duck Viral Enteritis Historic and Forecast Sales by Regions
  • 8.10 Inclusion Body Hepatitis Historic and Forecast Sales by Regions
  • 8.11 Coccidiosis Historic and Forecast Sales by Regions
  • 8.12 Avian Influenza Historic and Forecast Sales by Regions
  • 8.13 Marek's Disease Historic and Forecast Sales by Regions
  • 8.14 Newcastle Disease Historic and Forecast Sales by Regions
  • 8.15 Salmonella Historic and Forecast Sales by Regions
  • 8.16 Avian Encephalomyelitis Historic and Forecast Sales by Regions
  • 8.17 Fowl Cholera Historic and Forecast Sales by Regions

9 . GLOBAL POULTRY VACCINES MARKET SALES ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook Sales Analysis
  • 9.2. Introduction Sales Analysis
  • 9.3. North America Sales Analysis
    • 9.3.1. Overview, Historic and Forecast Sales Analysis
    • 9.3.2. North America By Segment Sales Analysis
    • 9.3.3. North America By Country Sales Analysis
    • 9.3.4. United State Sales Analysis
    • 9.3.5. Canada Sales Analysis
    • 9.3.6. Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1. Overview, Historic and Forecast Sales Analysis
    • 9.4.2. Europe by Segment Sales Analysis
    • 9.4.3. Europe by Country Sales Analysis
    • 9.4.4. United Kingdom Sales Analysis
    • 9.4.5. France Sales Analysis
    • 9.4.6. Germany Sales Analysis
    • 9.4.7. Italy Sales Analysis
    • 9.4.8. Russia Sales Analysis
    • 9.4.9. Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1. Overview, Historic and Forecast Sales Analysis
    • 9.5.2. Asia Pacific by Segment Sales Analysis
    • 9.5.3. Asia Pacific by Country Sales Analysis
    • 9.5.4. China Sales Analysis
    • 9.5.5. India Sales Analysis
    • 9.5.6. Japan Sales Analysis
    • 9.5.7. South Korea Sales Analysis
    • 9.5.8. Australia Sales Analysis
    • 9.5.9. Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1. Overview, Historic and Forecast Sales Analysis
    • 9.6.2. Latin America by Segment Sales Analysis
    • 9.6.3. Latin America by Country Sales Analysis
    • 9.6.4. Brazil Sales Analysis
    • 9.6.5. Argentina Sales Analysis
    • 9.6.6. Peru Sales Analysis
    • 9.6.7. Chile Sales Analysis
    • 9.6.8. Rest of Latin America Sales Analysis
  • 9.7. Middle East Africa Sales Analysis
    • 9.7.1. Overview, Historic and Forecast Sales Analysis
    • 9.7.2. Middle East Africa by Segment Sales Analysis
    • 9.7.3. Middle East Africa by Country Sales Analysis
    • 9.7.4. Saudi Arabia Sales Analysis
    • 9.7.5. UAE Sales Analysis
    • 9.7.6. Israel Sales Analysis
    • 9.7.7. South Africa Sales Analysis
    • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE POULTRY VACCINES COMPANIES

  • 10.1. Poultry Vaccines Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF POULTRY VACCINES INDUSTRY

  • 11.1. Top 10 Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Boehringer Ingelheim International GmbH
    • 11.3.1. Company Overview
    • 11.3.2. Company Revenue
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. Ceva
    • 11.4.1. Company Overview
    • 11.4.2. Company Revenue
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. Zoetis
    • 11.5.1. Company Overview
    • 11.5.2. Company Revenue
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. Elanco
    • 11.6.1. Company Overview
    • 11.6.2. Company Revenue
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. Intervet Inc.
    • 11.7.1. Company Overview
    • 11.7.2. Company Revenue
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. Merck Co. Inc.
    • 11.8.1. Company Overview
    • 11.8.2. Company Revenue
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. Hester Biosciences Limited
    • 11.9.1. Company Overview
    • 11.9.2. Company Revenue
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. Vaxxinova International BV
    • 11.10.1. Company Overview
    • 11.10.2. Company Revenue
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. Venkys India
    • 11.11.1. Company Overview
    • 11.11.2. Company Revenue
    • 11.11.3. Products
    • 11.11.4. Recent Developments
  • 11.12. Calier
    • 11.12.1. Company Overview
    • 11.12.2. Company Revenue
    • 11.12.3. Products
    • 11.12.4. Recent Developments
  • 11.13. KM Biologics
    • 11.13.1. Company Overview
    • 11.13.2. Company Revenue
    • 11.13.3. Products
    • 11.13.4. Recent Developments
  • 11.14. Phibro Animal Health Corporation
    • 11.14.1. Company Overview
    • 11.14.2. Company Revenue
    • 11.14.3. Products
    • 11.14.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Application (USD MN)
  • Broiler Market Sales by Geography (USD MN)
  • Layer Market Sales by Geography (USD MN)
  • Breeder Market Sales by Geography (USD MN)
  • Analysis Market by Product (USD MN)
  • Attenuated Live Vaccines Market Sales by Geography (USD MN)
  • Inactivated Vaccines Market Sales by Geography (USD MN)
  • Subunit Vaccines Market Sales by Geography (USD MN)
  • DNA Vaccines Market Sales by Geography (USD MN)
  • Recombinant Vaccines Market Sales by Geography (USD MN)
  • Analysis by Disease Type (USD MN)
  • Infectious Bronchitis Market Sales by Geography (USD MN)
  • Infectious Bursal Diseases Market Sales by Geography (USD MN)
  • Infectious Laryngotracheitis Market Sales by Geography (USD MN)
  • Egg Drop Syndrome Market Sales by Geography (USD MN)
  • Adenovirus Market Sales by Geography (USD MN)
  • Duck Viral Enteritis Market Sales by Geography (USD MN)
  • Inclusion Body Hepatitis Market Sales by Geography (USD MN)
  • Coccidiosis Market Sales by Geography (USD MN)
  • Avian Influenza Market Sales by Geography (USD MN)
  • Marek's Disease Market Sales by Geography (USD MN)
  • Newcastle Disease Market Sales by Geography (USD MN)
  • Salmonella Market Sales by Geography (USD MN)
  • Avian Encephalomyelitis Market Sales by Geography (USD MN)
  • Fowl Cholera Market Sales by Geography (USD MN)
  • Global Poultry Vaccines Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Poultry Vaccines Report
  • Market Research Process
  • Market Research Methodology
  • Global Poultry Vaccines Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by Disease Type
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Application (USD MN)
  • Broiler Market Sales by Geography (USD MN)
  • Layer Market Sales by Geography (USD MN)
  • Breeder Market Sales by Geography (USD MN)
  • Global Market Analysis by Product (USD MN)
  • Attenuated Live Vaccines Market Sales by Geography (USD MN)
  • Inactivated Vaccines Market Sales by Geography (USD MN)
  • Subunit Vaccines Market Sales by Geography (USD MN)
  • DNA Vaccines Market Sales by Geography (USD MN)
  • Recombinant Vaccines Market Sales by Geography (USD MN)
  • Global Market Analysis by Disease Type (USD MN)
  • Infectious Bronchitis Market Sales by Geography (USD MN)
  • Infectious Bursal Diseases Market Sales by Geography (USD MN)
  • Infectious Laryngotracheitis Market Sales by Geography (USD MN)
  • Egg Drop Syndrome Market Sales by Geography (USD MN)
  • Adenovirus Market Sales by Geography (USD MN)
  • Duck Viral Enteritis Market Sales by Geography (USD MN)
  • Inclusion Body Hepatitis Market Sales by Geography (USD MN)
  • Coccidiosis Market Sales by Geography (USD MN)
  • Avian Influenza Market Sales by Geography (USD MN)
  • Marek's Disease Market Sales by Geography (USD MN)
  • Newcastle Disease Market Sales by Geography (USD MN)
  • Salmonella Market Sales by Geography (USD MN)
  • Avian Encephalomyelitis Market Sales by Geography (USD MN)
  • Fowl Cholera Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East Africa Market by Revenue
  • Recent Development in Industry
  • Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.